C12N 2500/00
Specific components of cell culture medium
C12N2500/00 (Specific components of cell culture medium) appears on 3,820 US grants and 7,071 published applications in this corpus.
Search patents in C12N- Granted patents
- 3,820
- Published applications
- 7,071
- Assignees
- 2,842
- Inventors
- 12,806
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 3 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 3 | 0 |
| 1981 | 3 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 7 | 0 |
| 1985 | 7 | 0 |
| 1986 | 4 | 0 |
| 1987 | 6 | 0 |
| 1988 | 8 | 0 |
| 1989 | 7 | 0 |
| 1990 | 5 | 0 |
| 1991 | 10 | 0 |
| 1992 | 21 | 0 |
| 1993 | 12 | 0 |
| 1994 | 22 | 0 |
| 1995 | 22 | 0 |
| 1996 | 28 | 0 |
| 1997 | 49 | 0 |
| 1998 | 64 | 0 |
| 1999 | 53 | 0 |
| 2000 | 55 | 0 |
| 2001 | 50 | 29 |
| 2002 | 57 | 108 |
| 2003 | 57 | 132 |
| 2004 | 41 | 131 |
| 2005 | 44 | 179 |
| 2006 | 47 | 145 |
| 2007 | 47 | 153 |
| 2008 | 57 | 159 |
| 2009 | 59 | 160 |
| 2010 | 80 | 224 |
| 2011 | 86 | 223 |
| 2012 | 112 | 221 |
| 2013 | 117 | 213 |
| 2014 | 147 | 228 |
| 2015 | 153 | 289 |
| 2016 | 188 | 308 |
| 2017 | 176 | 322 |
| 2018 | 197 | 336 |
| 2019 | 214 | 392 |
| 2020 | 216 | 414 |
| 2021 | 197 | 485 |
| 2022 | 202 | 475 |
| 2023 | 211 | 547 |
| 2024 | 228 | 503 |
| 2025 | 260 | 407 |
| 2026 | 186 | 288 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2500/30Organic componentsIndexing code2,151
- C12N 2500/05Inorganic componentsIndexing code1,196
- C12N 2500/90Serum-free medium, which may still contain naturally-sourced componentsIndexing code967
- C12N 2500/70Undefined extractsIndexing code569
- C12N 2500/02AtmosphereIndexing code398
- C12N 2500/60BufferIndexing code218
- C12N 2500/99Serum-free mediumIndexing code196
- C12N 2500/98Xeno-free medium and culture conditionsIndexing code126
All 9 subgroupsShow fewer
Recent patents
- Induced pluripotent stem cell derived glial enriched progenitor cells for the treatment of white matter stroke6 Oct 2026US 12,751,976 B2The Regents of the University of California
- Immortalized keratinocytes, lentivirus for keratinocyte immortalization, and methods of use6 Oct 2026US 12,753,388 B2Regents of the University of Minnesota
- Method for producing cell sheet6 Oct 2026US 12,753,390 B2Kaneka Corporation
- High-purity mesenchymal stem cells6 Oct 2026US 12,753,391 B2Purec Co., Ltd.
- Composition for enhancing reprogramming efficiency from somatic cell to induced pluripotent stem cell, comprising mTOR activator, and method for enhancing reprogramming efficiency by using same6 Oct 2026US 12,753,394 B2Korea University Research and Business Foundation
- Transgenic model of human cardiomyopathy8 Oct 2026US 2026/0305586 A1Stichting Genetische Hartspierziekte PLN
- Methods and compositions related to platelet releasate and platelet-rich fibrin8 Oct 2026US 2026/0306546 A1Biobridge Global
- Production of a probiotic composition8 Oct 2026US 2026/0306558 A1Blis Technologies Limited
- Metabolically enhanced vd1 t cells and uses thereof8 Oct 2026US 2026/0308518 A1
- In vitro culturing method for inducing ovarian follicles from fetal ovarian cells of primate8 Oct 2026US 2026/0308531 A1Kyoto University
Most cited
By later US patents
- Isolation of precursor cells from hematopoietic and nonhematopoietic tissues and their use in vivo bone and cartilage regeneration549US 6,200,606 B1DePuy Orthopaedics, Inc. · 2001
- Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins500US 5,122,469 AGenentech, Inc. · 1992
- Technique for healing lesions in cartilage498US 4,846,835 A1989
- Protein-free culture medium464US 4,767,704 AColumbia University in the City of New York · 1988
- Serum-free, synthetic, completely chemically defined tissue culture media450US 4,657,866 A1987